| 标题 |
专利、报告等 Novel regimens for persistent/recurrent rare epithelial ovarian carcinomas (EOCs) selected according to biomarker status: ENGOT-GYN2/GOG-3051/BOUQUET phase II study results
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Ray-Coquard IL, Miller R, Brown J, et al. Novel regimens for persistent/recurrent rare epithelial ovarian carcinomas (EOCs) selected according to biomarker status: ENGOT-GYN2/GOG-3051/BOUQUET phase II study results. ESMO Open 2025; 10(Supplement 5): 105199. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)